Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2008 | 03-2008 | 12-2007 | 09-2007 | 06-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 188,200 | 162,900 | 141,800 | 175,700 | 164,900 |
| Marketable Securities | 19,900 | 26,700 | 49,400 | N/A | N/A |
| Receivables | 173,300 | 155,300 | 145,300 | 136,700 | 137,400 |
| Inventories | 136,800 | 139,500 | 152,600 | 158,300 | 143,500 |
| Income taxes - deferred | 30,600 | 34,800 | 30,200 | 25,900 | 25,400 |
| Other current assets | 44,600 | 41,600 | 41,700 | 0 | 0 |
| TOTAL | $635,100 | $591,600 | $586,400 | $564,800 | $541,200 |
| Non-Current Assets | |||||
| PPE Net | 224,600 | 223,600 | 228,200 | 228,000 | 220,200 |
| Investments And Advances | 27,100 | 28,000 | 34,300 | 36,800 | 25,100 |
| Intangibles | 425,300 | 427,600 | 472,800 | 444,700 | 445,200 |
| Other Non-Current Assets | 36,200 | 39,500 | 28,100 | 25,400 | 20,100 |
| TOTAL | $713,200 | $718,700 | $763,400 | $734,900 | $710,600 |
| Total Assets | $1,348,300 | $1,310,300 | $1,349,800 | $1,299,700 | $1,251,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 150,000 | 150,000 | 150,000 | 150,000 |
| Accounts payable and accrued liabilities | 226,600 | 241,600 | 63,900 | 198,800 | 173,600 |
| Accrued Expenses | N/A | N/A | 161,500 | N/A | N/A |
| TOTAL | $226,600 | $391,600 | $380,100 | $348,800 | $323,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 141,700 | 62,900 | 61,700 | 61,200 | 57,600 |
| Other Non-Current Liabilities | 82,700 | 78,200 | 73,000 | 65,900 | 63,100 |
| TOTAL | $224,400 | $141,100 | $134,700 | $127,100 | $120,700 |
| Total Liabilities | $451,000 | $532,700 | $514,800 | $475,900 | $444,300 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 674,733 | 658,256 | 680,279 | 680,462 | 687,330 |
| Common Shares | 72,700 | 68,900 | 68,600 | 68,400 | 67,900 |
| Retained earnings | 606,500 | 566,800 | 548,600 | 532,800 | 503,700 |
| Other shareholders' equity | 19,100 | 16,900 | 7,200 | 3,300 | -9,100 |
| TOTAL | $897,300 | $777,600 | $835,000 | $823,800 | $807,500 |
| Total Liabilities And Equity | $1,348,300 | $1,310,300 | $1,349,800 | $1,299,700 | $1,251,800 |